Karen Bisnauthsing - Concepedia

Author

Karen Bisnauthsing

Guy's and St Thomas' NHS Foundation Trust ORCID

Also Known As

A Mazzella, Guy Thwaites, J Rossdale, K Birchall, K Bisnauthsing, K. Birchall, K. Bisnauthsing, K.N. Bisnauthsing, Karen Bisnauthsing, Karen N. Bisnauthsing

Publications

13.8K

Citations

H-Index

Concepts

All Affiliations

Guy's and St Thomas' NHS Foundation Trust King's College London University College London University of Oxford London School of Hygiene & Tropical Medicine

About

Karen Bisnauthsing is an author at Guy's and St Thomas' NHS Foundation Trust specializing in medicine, covid-19, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.3K
2	Epidemiology	4	4	513
3	Public Health	2	2	55
4	Allergy	1	1	28
5	Gastroenterology	1	1	25

Karen Bisnauthsing

Publications

12.8K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2020	5K
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans Jeffrey Seow, Carl Graham, Blair Merrick, Nature Microbiology	2020	1.4K
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2021	1.2K
A dynamic COVID-19 immune signature includes associations with poor prognosis Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, Nature Medicine	2020	1K
Oral versus Intravenous Antibiotics for Bone and Joint Infection Ho Kwong Li, Ines Rombach, Rhea Zambellas, New England Journal of Medicine	2019	850
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Rachael A Evans, Olivia C. Leavy, Matthew Richardson, The Lancet Respiratory Medicine	2022	407
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection Jeffrey Seow, Carl Graham, Blair Merrick, Abstract AntibodyLong CovidViral PersistenceViral DiagnosticsDisease Severity	2020	364
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289

Page 1